Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Merrimack Pharmaceuticals Inc (NASDAQ:MACK)

10.50
Delayed Data
As of Aug 28
 +0.07 / +0.67%
Today’s Change
6.38
Today|||52-Week Range
13.84
-7.08%
Year-to-Date
No recent news for Merrimack Pharmaceuticals Inc.

Today’s Trading

Previous close10.43
Today’s open10.31
Day’s range10.31 - 11.00
Volume2,617,481
Average volume (3 months)1,329,368
Market cap$1.2B
Dividend yield--
Data as of 3:59pm ET, 08/28/2015

Growth & Valuation

Earnings growth (last year)+39.39%
Earnings growth (this year)-40.89%
Earnings growth (next 5 years)+5.61%
Revenue growth (last year)+115.03%
P/E ratioNM
Price/Sales11.48
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CLLSCellectis SA+0.51+1.56%
ZIOPZIOPHARM Oncology In...+0.32+3.69%
RGENRepligen Corp-0.09-0.26%
DVAXDynavax Technologies...+1.31+4.60%
Data as of 3:59pm ET, 08/28/2015

Financials

Next reporting dateNovember 11, 2015
EPS forecast (this quarter)-$0.38
Annual revenue (last year)$102.8M
Annual profit (last year)-$83.3M
Net profit margin-81.06%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Robert J. Mulroy
Head-
Corporate Operations
William M. McClements
Corporate headquarters
Cambridge, Massachusetts

Forecasts

Partner Offers